Stay updated on DC-806 in Plaque Psoriasis Clinical Trial
Sign up to get notified when there's something new on the DC-806 in Plaque Psoriasis Clinical Trial page.

Latest updates to the DC-806 in Plaque Psoriasis Clinical Trial page
- CheckyesterdayChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.8%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check23 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check51 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check66 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed study information regarding the efficacy and safety of DC-806 for plaque psoriasis, while retaining some identifiers and a description of the study's blinding process.SummaryDifference25%
- Check73 days agoChange DetectedThe web page has been updated to reflect the results of a clinical study on DC-806 for treating moderate to severe plaque psoriasis, including specific dosing information and results reporting dates. Key details about the study's design and participant outcomes have been clarified.SummaryDifference22%
Stay in the know with updates to DC-806 in Plaque Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DC-806 in Plaque Psoriasis Clinical Trial page.